SLC7A11 and glioma: EGFR-expressing glioma cells exhibit increased glutamate export, cystine uptake, and GSH biosynthesis, while targeted inhibition of SLC7A11 suppresses the antioxidant capacity, growth, and invasion of EGFR-overexpressing cancer cells.